换一批
换一批A novel RNA sequencing-based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma.
第一作者：
Fumao,Bai
第一单位：
Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, China.
作者：
主题词
癌, 肝细胞(Carcinoma, Hepatocellular);基因表达谱(Gene Expression Profiling);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);肝肿瘤(Liver Neoplasms);微RNAs(MicroRNAs);多元分析(Multivariate Analysis);肿瘤复发, 局部(Neoplasm Recurrence, Local);预后(Prognosis);比例危险度模型(Proportional Hazards Models);结果可重复性(Reproducibility of Results);危险因素(Risk Factors);序列分析, RNA(Sequence Analysis, RNA);存活率分析(Survival Analysis)
DOI
10.1002/1878-0261.12315
PMID
29719937
发布时间
2022-04-08
- 浏览18
Molecular oncology
1125-1137页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
